Cargando…

Resistance Profiles and Biological Characteristics of Rifampicin-Resistant Staphylococcus aureus Small-Colony Variants

BACKGROUND: Staphylococcus aureus (S. aureus) is a major contributor to nosocomial and community-acquired infections. S. aureus small colony variants (SCVs) which changed in relevant phenotype have made more limited and difficult for therapeutic options against S. aureus infections increasingly. Rif...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Xiangkuo, Fang, Renchi, Wang, Chong, Tian, Xuebin, Lin, Jie, Zeng, Weiliang, Zhou, Tieli, Xu, Chunquan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8071703/
https://www.ncbi.nlm.nih.gov/pubmed/33911880
http://dx.doi.org/10.2147/IDR.S301863
_version_ 1783683766320889856
author Zheng, Xiangkuo
Fang, Renchi
Wang, Chong
Tian, Xuebin
Lin, Jie
Zeng, Weiliang
Zhou, Tieli
Xu, Chunquan
author_facet Zheng, Xiangkuo
Fang, Renchi
Wang, Chong
Tian, Xuebin
Lin, Jie
Zeng, Weiliang
Zhou, Tieli
Xu, Chunquan
author_sort Zheng, Xiangkuo
collection PubMed
description BACKGROUND: Staphylococcus aureus (S. aureus) is a major contributor to nosocomial and community-acquired infections. S. aureus small colony variants (SCVs) which changed in relevant phenotype have made more limited and difficult for therapeutic options against S. aureus infections increasingly. Rifampicin is considered as the “last-resort” antibiotic against S. aureus. Our study investigated resistance profiles and biological characteristics of rifampicin-resistant S. aureus SCVs. METHODS: We collected S. aureus SCVs that were selected from 41 rifampicin-resistant clinical isolates. Then, biological characteristics, resistance spectrum, and rifampicin resistance mechanisms of tested S. aureus SCVs and corresponding parental strains were investigated by classic microbiological methods, agar dilution method, polymerase chain reaction (PCR). Moreover, the fitness cost of S. aureus SCVs, including growth, biofilm formation ability, and virulence profile, was also determined by bacterial growth curve assay, biofilm formation assay, and Galleria mellonella infection model. RESULTS: There were three S. aureus SCVs (JP310 SCVs, JP1450 SCVs, JP1486 SCVs) that were selected from 41 rifampicin-resistant S. aureus. S. aureus SCVs colonies were tiny, with decreased pigmentation, and the hemolysis circle was not obvious compared with corresponding parental strains. And SCVs could not be restored to normal-colony phenotype after hemin, menaquinone, or thymidine supplementation. Different rpoB mutations occurred in JP1486 SCVs. Antimicrobial susceptibility testing revealed MICs of SCVs were higher than corresponding parental strains. Besides, the growth ability and virulence of SCVs were lower, and biofilm formation ability of which increased compared with parental strains. CONCLUSION: S. aureus SCVs share the rifampicin resistance mechanisms with parental strains, although there were some differences in the position of rpoB mutations. Moreover, we found that the biological characteristics of SCVs were significantly different from corresponding parental strains. In contrast, decreased susceptibility to other antibiotics of SCVs was observed during phenotype switch. Furthermore, SCVs incur the fitness cost.
format Online
Article
Text
id pubmed-8071703
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-80717032021-04-27 Resistance Profiles and Biological Characteristics of Rifampicin-Resistant Staphylococcus aureus Small-Colony Variants Zheng, Xiangkuo Fang, Renchi Wang, Chong Tian, Xuebin Lin, Jie Zeng, Weiliang Zhou, Tieli Xu, Chunquan Infect Drug Resist Original Research BACKGROUND: Staphylococcus aureus (S. aureus) is a major contributor to nosocomial and community-acquired infections. S. aureus small colony variants (SCVs) which changed in relevant phenotype have made more limited and difficult for therapeutic options against S. aureus infections increasingly. Rifampicin is considered as the “last-resort” antibiotic against S. aureus. Our study investigated resistance profiles and biological characteristics of rifampicin-resistant S. aureus SCVs. METHODS: We collected S. aureus SCVs that were selected from 41 rifampicin-resistant clinical isolates. Then, biological characteristics, resistance spectrum, and rifampicin resistance mechanisms of tested S. aureus SCVs and corresponding parental strains were investigated by classic microbiological methods, agar dilution method, polymerase chain reaction (PCR). Moreover, the fitness cost of S. aureus SCVs, including growth, biofilm formation ability, and virulence profile, was also determined by bacterial growth curve assay, biofilm formation assay, and Galleria mellonella infection model. RESULTS: There were three S. aureus SCVs (JP310 SCVs, JP1450 SCVs, JP1486 SCVs) that were selected from 41 rifampicin-resistant S. aureus. S. aureus SCVs colonies were tiny, with decreased pigmentation, and the hemolysis circle was not obvious compared with corresponding parental strains. And SCVs could not be restored to normal-colony phenotype after hemin, menaquinone, or thymidine supplementation. Different rpoB mutations occurred in JP1486 SCVs. Antimicrobial susceptibility testing revealed MICs of SCVs were higher than corresponding parental strains. Besides, the growth ability and virulence of SCVs were lower, and biofilm formation ability of which increased compared with parental strains. CONCLUSION: S. aureus SCVs share the rifampicin resistance mechanisms with parental strains, although there were some differences in the position of rpoB mutations. Moreover, we found that the biological characteristics of SCVs were significantly different from corresponding parental strains. In contrast, decreased susceptibility to other antibiotics of SCVs was observed during phenotype switch. Furthermore, SCVs incur the fitness cost. Dove 2021-04-21 /pmc/articles/PMC8071703/ /pubmed/33911880 http://dx.doi.org/10.2147/IDR.S301863 Text en © 2021 Zheng et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Zheng, Xiangkuo
Fang, Renchi
Wang, Chong
Tian, Xuebin
Lin, Jie
Zeng, Weiliang
Zhou, Tieli
Xu, Chunquan
Resistance Profiles and Biological Characteristics of Rifampicin-Resistant Staphylococcus aureus Small-Colony Variants
title Resistance Profiles and Biological Characteristics of Rifampicin-Resistant Staphylococcus aureus Small-Colony Variants
title_full Resistance Profiles and Biological Characteristics of Rifampicin-Resistant Staphylococcus aureus Small-Colony Variants
title_fullStr Resistance Profiles and Biological Characteristics of Rifampicin-Resistant Staphylococcus aureus Small-Colony Variants
title_full_unstemmed Resistance Profiles and Biological Characteristics of Rifampicin-Resistant Staphylococcus aureus Small-Colony Variants
title_short Resistance Profiles and Biological Characteristics of Rifampicin-Resistant Staphylococcus aureus Small-Colony Variants
title_sort resistance profiles and biological characteristics of rifampicin-resistant staphylococcus aureus small-colony variants
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8071703/
https://www.ncbi.nlm.nih.gov/pubmed/33911880
http://dx.doi.org/10.2147/IDR.S301863
work_keys_str_mv AT zhengxiangkuo resistanceprofilesandbiologicalcharacteristicsofrifampicinresistantstaphylococcusaureussmallcolonyvariants
AT fangrenchi resistanceprofilesandbiologicalcharacteristicsofrifampicinresistantstaphylococcusaureussmallcolonyvariants
AT wangchong resistanceprofilesandbiologicalcharacteristicsofrifampicinresistantstaphylococcusaureussmallcolonyvariants
AT tianxuebin resistanceprofilesandbiologicalcharacteristicsofrifampicinresistantstaphylococcusaureussmallcolonyvariants
AT linjie resistanceprofilesandbiologicalcharacteristicsofrifampicinresistantstaphylococcusaureussmallcolonyvariants
AT zengweiliang resistanceprofilesandbiologicalcharacteristicsofrifampicinresistantstaphylococcusaureussmallcolonyvariants
AT zhoutieli resistanceprofilesandbiologicalcharacteristicsofrifampicinresistantstaphylococcusaureussmallcolonyvariants
AT xuchunquan resistanceprofilesandbiologicalcharacteristicsofrifampicinresistantstaphylococcusaureussmallcolonyvariants